Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population—an observational study from a tertiary care center in Karachi-Reference-Cited by-同舟云学术

Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population—an observational study from a tertiary care center in Karachi

Published:2022-12-29 Issue:1 Volume:80 Page:64-70
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Sheikh Aisha^ORCID,Das Bhagwan^ORCID,Sattar Saadia^ORCID,Islam Najmul^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-022-03290-7.pdf

Reference27 articles.

1. Federation I. IDF Diabetes Atlas, Tenth edition. International Diabetes; 2021

2. Hassanein M., Afandi B., Ahmedani M.Y., Alamoudi R.M., Alawadi F., Bajaj H.S., Basit A., Bennakhi A., El Sayed A.A., Hamdy O. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res. Clin. Pract.109185. Vol 185 (2022). https://doi.org/10.1016/j.diabres.2021.109185

3. S.M. Babineaux, D. Toaima, K.S. Boye, A. Zagar, A. Tahbaz, A. Jabbar, M. Hassanein, Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet. Med. 32, 819–828 (2015). https://doi.org/10.1111/dme.12685

4. I. Salti, E. Bénard, B. Detournay, M. Bianchi-Biscay, C. Le Brigand, C. Voinet, A. Jabbar, A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27, 2306–2311 (2004). https://doi.org/10.2337/diacare.27.10.2306

5. M. Hassanein, F.F. Al Awadi, K.E.S. El Hadidy, S.S. Ali, A. Echtay, K. Djaballah, C. Dessapt-Baradez, F.A.K. Khazaal, M.O. Abu-Hijleh, A. Al Shaikh, M.E.H. Gharbi, N. Shehadeh, A. Bennakhi, M. Al Arouj, The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: an international prospective study (DAR-MENA T2DM).Diabetes Res. Clin. Pract. 151, 275–284 (2019). https://doi.org/10.1016/j.diabres.2019.02.020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-time Usage of SGLT2 Inhibitors in Patients with Type 2 Diabetes Who Are Fasting Ramadan: Efficacy and Safety;2024-08-06

2. Diabetes and Ramadan Fasting (2023): The Year in Review;Journal of Diabetes and Endocrine Practice;2024-04

3. Analysing uric acid levels to assess the effectiveness of dapagliflozin;Clinical Nutrition ESPEN;2024-02

4. Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01

5. Ramadan Fasting and Diabetes (2022): The Year in Review;Journal of Diabetes and Endocrine Practice;2023-04-03